Transmission reduction, health benefits, and upper-bound costs of interventions to improve retention on antiretroviral therapy: a combined analysis of three mathematical models
Authors:
Open Access
- 9 August 2022
- journal article
- research article
- Published by Elsevier in The Lancet Global Health
- Vol. 10 (9) , e1298-e1306
Abstract
No abstract availableKeywords
Funding Information
- World Health Organization
- National Institutes of Health
- Wellcome Trust
- United States Agency for International Development
- UK Research and Innovation
- Bill and Melinda Gates Foundation
This publication has 33 references indexed in Scilit:
- Reflecting the real value of health care resources in modelling and cost-effectiveness studies—The example of viral load informed differentiated carePLOS ONE, 2018
- Changing the South African national antiretroviral therapy guidelines: The role of cost modellingPLOS ONE, 2017
- Revealed willingness-to-pay versus standard cost-effectiveness thresholds: Evidence from the South African HIV Investment CasePLOS ONE, 2017
- Improving ART programme retention and viral suppression are key to maximising impact of treatment as prevention – a modelling studyBMC Infectious Diseases, 2017
- Universal test, treat, and keep: improving ART retention is key in cost-effective HIV control in UgandaBMC Infectious Diseases, 2017
- Age-targeted HIV treatment and primary prevention as a ‘ring fence’ to efficiently interrupt the age patterns of transmission in generalized epidemic settings in South AfricaInternational Health, 2016
- Sustainable HIV treatment in Africa through viral-load-informed differentiated careNature, 2015
- Impact and Cost-Effectiveness of Hypothetical Strategies to Enhance Retention in Care within HIV Treatment Programs in East AfricaValue in Health, 2015
- OptimaJAIDS Journal of Acquired Immune Deficiency Syndromes, 2015
- Dropout and re-enrollmentAIDS, 2014